International Clinical Trial: Retrospective and Prospective Observational Study on Aponermin-based Regimens in the Treatment of Relapsed and Refractory Multiple Myeloma with Thrombocytopenia

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132654) titled 'Retrospective and Prospective Observational Study on Aponermin-based Regimens in the Treatment of Relapsed and Refractory Multiple Myeloma with Thrombocytopenia' on Sept. 16.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital

Condition: Relapsed and Refractory Multiple Myeloma with Thrombocytopenia

Intervention: Epinamine group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-16

Target Sample Size: Epinamine group:30;Non-Epinamine group:30;

Countries ...